Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome

PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 3, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Lower Urinary Tract SymptomsOveractive Bladder Syndrome
Interventions
DRUG

MitoQ (mitoquinol mesylate)

MitoQ is an antioxidant molecule designed to target cell stress

OTHER

Placebo

Control capsules that contain all inactive ingredients found in the study drug capsules (i.e., placebo capsules do not contain mitoquinol mesylate)

Trial Locations (1)

06030

RECRUITING

UConn Health, Farmington

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

collaborator

American Urological Association

OTHER

collaborator

Urology Care Foundation

UNKNOWN

collaborator

Claude D. Pepper Older Americans Independence Center (OAIC)

UNKNOWN

lead

Iman Al-Naggar, PhD

OTHER